This is scary as it keeps growing. Patients in 35 states now have had this injection and the infection is not contagious. So far 5 people have died and 35 patients have become sick. I smell a lawsuit or two on the deaths and for good reason here. California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Virginia, Texas and West Virginia are all states who receive product from the New England Compounding Center. The Saint Thomas Outpatient Neurosurgery Center in Nashville received 2,000 vials and is where the infections began and the clinic has now been closed to continue the investigation. The danger here too is that the infection can take weeks to to incubate.
One investigator found some foreign material in a vial and ran it under the microscope and found fungal matter so it’s looking like the origin has been found. Anyone who has received a lower back injection should contact their doctor or clinic and inquire if they happened to be using any of the contaminated products. There’s treatment but it requires the patient to be hospitalized and given medication via an IV and timing is important to survival. The treatment could go on for months. BD
(CNN) -- Patients in 23 states could have been exposed to tainted medications that are being linked to dangerous fungal meningitis infections, health officials announced Thursday.
According to the U.S. Centers for Disease Control and Prevention, 35 people in six states now meet the criteria for a non-contagious, fungal form of meningitis, up from 26 just a day ago.
Each one of these patients had been injected with a preservative-free steroid called methylprednisolone acetate manufactured by New England Compounding Center (NECC) in Framingham Massachusetts, according to U.S. Food and Drug Administration and CDC officials.
NECC voluntarily recalled three lots of steroids last week and voluntarily shut down production at the entire facility on Wednesday, according to Ilisa Bernstein, director of the FDA's Center for Drug Evaluation and Research.
After analyzing the foreign material under a microscope, it was determined to be a fungal matter. Further tests to determine what type of fungus this may be is still under way.